by Heather Landi  – Fierce Healthcare – Walgreens is expanding its specialty pharmacy services to offer gene and cell therapy services, supported by a dedicated 18,000-square-foot center in Pittsburgh, the company announced Thursday. The service is part of the retail pharmacy company’s newly integrated business unit, Walgreens Specialty Pharmacy, that rolls up all its specialty pharmacy segment assets, including AllianceRx. The new business, formerly called AllianceRx Walgreens Pharmacy, is under the Walgreens U.S. retail pharmacy segment. Read More Click Here The post Providers Walgreens ..read more

By – ISSCR – The international Society for Stem Cell Research will host a free webinar celebrating Earth Day April 22, 2024 Program Description: Celebrate Earth Day by diving into the science of conservation, where the potential of stem cells is harnessed to foster a more sustainable and biodiverse future. This enlightening online webinar co-hosted by Ashlee Hutchinson and Jun Wu will spotlight the revolutionary intersection of induced pluripotent stem cells (iPSCs), embryo models and genome engineering technologies with the noble cause of species preservation. As our planet faces unprecedent ..read more

By CiRA – Kyoto University – In a recent study, Professor Shimpei Gotoh (Department of Clinical Application) and Junior Associate Professor Kazuo Takayama (Department of Cell Growth and Differentiation) teamed up to construct a novel in vitro culture system for alveolar and airway epithelial cells, employing a biomaterials engineering method known as micro-patterning technique, and using the newly devised system to simulate viral infections by SARS-CoV-2 variants. Read more – Click here to view article The post Micro-patterning-a new system to induce alveolar and airway epithelial cells first ..read more

By Aspen Neuroscience SAN DIEGO, April 17, 2024 /PRNewswire/ — Aspen Neuroscience, Inc. announced that the first patient has been dosed in the ASPIRO trial, a Phase 1/2a open label clinical trial to assess safety and tolerability of ANPD001, an autologous, dopaminergic neuron cell replacement therapy for participants with moderate to severe Parkinson’s disease (PD). Aspen Neuroscience is a private biotechnology company developing personalized regenerative therapies. Read the full press release here The post Clinical Trial for Parkinson’s Disease – First-in-Human Phase 1/2a Autologous Neur ..read more

by Joseph Choi – The Hill – An increase in cancers among people 55 years old and younger may be related to accelerated aging in recent generations, according to a study presented at a conference earlier this month. Experts say years of research support this, though more questions remain to be answered. Researchers from the Washington University in St. Louis’s medical school presented the findings from their study on accelerated aging earlier this month at the American Association for Cancer Research annual meeting. Watch video and read more – click here to view  article The post Accelerat ..read more

By Jamie Morton – The New Zealand Herald – A groundbreaking, home-grown cancer therapy trial just hit another milestone and there are hopes to bring it to Kiwis, writes Jamie Morton. Michele Leggott remembers the morning of February 8, 2023, with crystal clarity. The prominent Auckland poet sat trembling in a tiny clinical office on the seventh floor of Wellington Hospital, with husband Mark by her side. The doctor ran through some quick questions about her sleep and diet, then cut to the chase. “We’re looking at a PET scan you did yesterday, and there is no active lymphoma,” he told her with ..read more

by Mayo Clinic – MedicalXpress – A Mayo Clinic study shows stem cells derived from patients’ own fat are safe and may improve sensation and movement after traumatic spinal cord injuries. The findings from the Phase I clinical trial appear in Nature Communications. The results of this early research offer insights into the potential of cell therapy for people living with spinal cord injuries and paralysis for whom options to improve function are extremely limited. In the study of 10 adults, the research team noted seven participants demonstrated improvements based on the American Spinal Injury ..read more

by Elena Garrido, Miguel Hernandez University of Elche – MedXpress – The development of the cerebral cortex largely depends on the stem cells responsible for generating neurons, known as radial glial cells. Until now, it was believed that these stem cells generated neurons following a simple process, that is, a single cell lineage. However, a study led by the Neurogenesis and cortical expansion laboratory, headed by researcher Víctor Borrell at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University (UMH) of Elche ..read more

by Jen Brogan – PharmaTimes – Researchers from King’s College London’s (KCL) Comprehensive Cancer Centre have identified a key mechanism that governs how bone marrow stem cells work, which could potentially lead to new therapeutic pathways. The findings from the study will help researchers further understand the key principles involved in stem cell biology and could provide new avenues for the development of efficient stem cell therapeutics. Read More – Click Here The post Key mechanism controlling bone marrow stem cells could lead to new therapies first appeared on Regenerative Medicine Found ..read more

by Susan Buckles –  Mayo Clinic – Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to match and susceptible to rejection, Mayo Clinic researchers discovered. Their pioneering research focuses on using CAR-T cells derived from the patient’s own immune system to prevent rejection of donated organs… Read more – click here to view article The post Could CAR-T cell therapy improve kidney transplants? first appeared on Regenerative Medicine Foundation ..read more